Por: ABC News Health November 04, 2022
Pfizer and BioNTech have launched a clinical trial on a vaccine targeting both COVID-19 and influenza, the companies Thursday.The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the companies said. The follow-up period for each participant will be six months.In this Sept. 8, 2022, file photo, a teenager receives the Pfizer-BioNTech COVID-19 booster... + full article
The Hill USA Health November 04, 2022
Pfizer and BioNTech have launched a phase 1 trial for an mRNA-based vaccine that would target both COVID-19 and the influenza virus. , the vaccine candidate is a combination of Pfizer’s flu vaccine candidate, which is in phase 3 clinical development, and the company’s... + más
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
Sheldon Jacobson and Janet Jokela: Will we have a severe flu season? It doesn’t need to be that way. | Chicago Tribune
ABC7 USA World November 04, 2022
Thursday.The phase 1 trial is being done in the United States with 180 participants between the ages of 18 and 64, with the first participant dosed this week, the companies said. The follow-up period for each participant will be six months.By combining both indications in one... + más
Pfizer, BioNTech launch phase 1 trial on combined COVID-19 and flu vaccine | ABC News
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
WPTV USA Nation November 03, 2022
Pfizer and BioNTech announced it is working on a combined COVID-19 and flu vaccine as it began trials this week.The companies said that 180 U.S. adults ages 18-64 are part of the Phase 1 study. It administered the first dose of the combined vaccine this week.The vaccine combines... + más
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Boston Globe USA Business October 08, 2022
Pfizer and BioNTech, the duo behind the world’s most widely used COVID-19 vaccine, and one of the most successful pharmaceutical products of all time, are developing a trio of new vaccines that could spur stronger, broader, and longer-lasting immunity to the... + más
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
About iurex | Privacy Policy | Disclaimer |